Myeloproliferative disorders: premalignant, stem cell, G1 diseases?

被引：7

作者：

Lelievre, H. ^{[1
]}

Ferrand, A.

Mozziconacci, M-J

Birnbaum, D.

Delaval, B.

机构：

[1] INSERM, UMR599, Ctr Res Cancerol Marseille, Oncol Mol Lab, F-13258 Marseille, France

[2] Inst J Paoli I Calmettes, F-13009 Marseille, France

[3] Univ Massachusetts, Sch Med, Biotech, Amherst, MA 01003 USA

来源：

LEUKEMIA | 2006年 / 20卷 / 09期

关键词：

D O I：

10.1038/sj.leu.2404295

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1475 / 1480

页数：6

共 29 条

[1] The survival kinases Akt and Pim as potential pharmacological targets [J].

Amaravadi, R ;

Thompson, CB .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2618-2624

[2] mTOR: a protein kinase switching between life and death [J].

Asnaghi, L ;

Bruno, P ;

Priulla, M ;

Nicolin, A .

PHARMACOLOGICAL RESEARCH, 2004, 50 (06) :545-549

[3] Oncogenic PI3K deregulates transcription and translation [J].

Bader, AG ;

Kang, SY ;

Zhao, L ;

Vogt, PK .

NATURE REVIEWS CANCER, 2005, 5 (12) :921-929

[4] Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer [J].

Chan, S .

BRITISH JOURNAL OF CANCER, 2004, 91 (08) :1420-1424

[5] Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors [J].

Collins, I ;

Garrett, MD .

CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (04) :366-373

[6]

Cortot A, 2006, B CANCER, V93, P19

[7]

Deininger Michael, 2005, J Natl Compr Canc Netw, V3, P757

[8]

Deininger MWN, 2001, CANCER RES, V61, P8005

[9] Myeloproliferative disorders:: the centrosome connection [J].

Delaval, B ;

Lelièvre, H ;

Birnbaum, D .

LEUKEMIA, 2005, 19 (10) :1739-1744

[10] A census of human cancer genes [J].

Futreal, PA ;

Coin, L ;

Marshall, M ;

Down, T ;

Hubbard, T ;

Wooster, R ;

Rahman, N ;

Stratton, MR .

NATURE REVIEWS CANCER, 2004, 4 (03) :177-183

← 1 2 3 →